BTIG Research Forecasts Strong Price Appreciation for Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical (NASDAQ:ISRG) had its price target raised by investment analysts at BTIG Research from $535.00 to $561.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. BTIG Research’s price objective indicates a potential upside of 3.85% from the company’s previous close.

Other research analysts also recently issued research reports about the company. Piper Sandler reiterated an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Leerink Partners increased their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Mizuho boosted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Truist Financial increased their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. Finally, Citigroup upped their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $526.06.

Intuitive Surgical Trading Up 0.7 %

NASDAQ:ISRG traded up $3.63 during midday trading on Tuesday, reaching $540.18. The company had a trading volume of 403,814 shares, compared to its average volume of 1,454,257. The firm has a market capitalization of $192.40 billion, a price-to-earnings ratio of 86.85, a PEG ratio of 5.39 and a beta of 1.39. The stock’s fifty day simple moving average is $505.63 and its 200-day simple moving average is $465.19. Intuitive Surgical has a 12-month low of $304.50 and a 12-month high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts expect that Intuitive Surgical will post 5.45 EPS for the current year.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now directly owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,539 shares of company stock valued at $26,112,364 over the last 90 days. 0.80% of the stock is owned by company insiders.

Institutional Trading of Intuitive Surgical

Several hedge funds have recently bought and sold shares of ISRG. Mirador Capital Partners LP raised its stake in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares in the last quarter. Consolidated Planning Corp lifted its stake in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after acquiring an additional 1,198 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares in the last quarter. Swiss National Bank increased its stake in shares of Intuitive Surgical by 0.3% during the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after acquiring an additional 3,400 shares during the period. Finally, ABLE Financial Group LLC bought a new stake in Intuitive Surgical during the third quarter worth approximately $604,000. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.